Guide To The WHO Executive Board: Access To Medicines, Noncommunicable Diseases, Non-State Actors 15/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Health Organization Executive Board meets next week. On the agenda are recommendations of a review group on the WHO Global Strategy on Public Health, Innovation and Intellectual Property, and WHO proposed actions to increase access to affordable and safe medicines and diagnosis. The Executive Board is also expected to consider a report on noncommunicable diseases, new possible organisations to enter into official relationships with WHO, and how to address the global burden of snakebites, including access to treatment.
USTR Notorious Markets: Online Ads Still Funding IP Infringement; Alibaba Fires Back About Report 12/01/2018 by William New, Intellectual Property Watch 1 Comment The Office of the United States Trade Representative today released its annual list of the worst outlaw online and physical markets around the world, citing a range of major sources of problems in every part of the world. The list this year highlights new technologies, identifies online advertising as a large revenue source for counterfeiters, and includes Chinese online market Taobao, owned by internet giant Alibaba, for the second year in a row, leading the company to claim bias and politics are at play.
Blockchain-Related Patents On Exponential Rise, Lawyer Says. Targets? China, US, UK 12/01/2018 by Catherine Saez, Intellectual Property Watch 1 Comment Patent applications related to blockchain technology are rising at exponential rate, according to a presentation given yesterday by a partner at United States law firm Rimon. Inventors are seeking intellectual property protection, bringing challenges into the blockchain ecosystem, such as infringement and patent trolls. He called for industry collaboration on IP, and the possibility of patent pools.
New Local Pharmaceutical Plant Expected To Enhance Access To Drugs In Kenya 12/01/2018 by Justus Wanzala for Intellectual Property Watch Leave a Comment Kenya’s pharmaceutical products manufacturing sector is hopeful it will experience significant growth after the Square Pharmaceuticals ltd (SPL) of Bangladesh commissioned a US$ 75 million plant in the East African nation this week. [A reminder: this story, like all of our stories, is completely free for almost every developing country in the world. Just sign up for a free password here!]
Morrison & Foerster’s 2018 Predictions On Intersection Of Technology And Law—From Web Scraping To Blockchain 12/01/2018 by Intellectual Property Watch Leave a Comment From the Morrison & Foerster Socially Aware blog: Happy 2018 to our readers! It has become a Socially Aware tradition to start the New Year with some predictions from our editors and contributors. With smart contracts on the horizon, the Internet of Things and cryptocurrencies in the spotlight, and a number of closely watched lawsuits moving toward resolution, 2018 promises to be an exciting year in the world of emerging technology and Internet law.
Japan Patent Office Invalidates The Word Mark “Bord’or” In Relation To Bordeaux Wines 12/01/2018 by Guest contributor for Intellectual Property Watch 1 Comment In a decision in an invalidation trial jointly claimed by INSTITUT NATIONAL DE L’ORIGINE ET DE LA QUALITE and CONSEIL INTERPROFESSIONNEL DU VIN DE BORDEAUX, the Invalidation Board of Japan Patent Office (JPO) ordered the invalidation of trademark registration no. 5737079 for a word mark “Bord’or” in script fonts (see below) in violation of Article 4(1)(vii) of the Trademark Law, writes Masaki Mikami.
How International IP Policy Reconfigured National Politics: An Interview With Prof. Ken Shadlen 11/01/2018 by Intellectual Property Watch 3 Comments The recently published book Coalitions and Compliance by Professor Ken Shadlen of the London School of Economics examines how international changes can reconfigure domestic politics. Since the late 1980s, developing countries have been subject to intense pressures regarding intellectual property rights. These pressures have been exceptionally controversial in the area of pharmaceuticals. Historically, fearing the economic and social costs of providing private property rights over knowledge, developing countries did not allow drugs to be patented. Now they must do so, an obligation with significant implications for industrial development and public health. This book analyses different forms of compliance with this new imperative in Latin America, comparing the politics of pharmaceutical patenting in Argentina, Brazil, and Mexico. The book focuses on two periods of patent politics: initial conflicts over how to introduce drug patents, and then subsequent conflicts over how these new patent systems function. Intellectual Property Watch recently conducted a Q&A with Prof. Shadlen, which appears below.
US IP Law – A Look At The Year Ahead 11/01/2018 by Steven Seidenberg for Intellectual Property Watch Leave a Comment In the coming year, one US Supreme Court case promises to dominate developments in America’s IP law. The upcoming decision in Oil States Energy Services v. Greene’s Energy Group could have major ramifications for patents, copyrights, trademarks, and the USPTO. But even as that case steals the limelight, 2018 could bring other significant changes to America’s IP law. Here are some of the key developments to watch for.
WIPO Respect For IP Conference To Be Held This Year In South Africa 10/01/2018 by William New, Intellectual Property Watch Leave a Comment In 2018, the World Intellectual Property Organization and other major international organisations are planning the second international conference on “Respect for IP,” referring to raising awareness of and building strategies for enforcement of intellectual property, this time in South Africa.
Artificial Intelligence Holds Enticing Promise, Needs Framework, Say OECD, Microsoft, IEEE 10/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment As artificial intelligence technology spreads its wings, governance issues are emerging, as are international discussions, including a range of activities planned for 2018. One of the panels of the December Internet Governance Forum in Geneva explored the policy questions, as panellists said artificial intelligence is unabatedly spreading to many areas of our lives with promises of economic growth and benefits, but with few regulations to frame it. Issues include ethics, privacy, biases, and lack of transparency.